These agents include angiotensin-converting-enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARBs), mineralocorticoid-receptor antagonists, and direct renin inhibitors, all of which can ...
New small-molecule inhibitors are being developed as well; Basel-based Novartis received approval for Tekturna (aliskiren), a direct renin inhibitor, just last year. Aldosterone synthesis ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果